SEC Form 4 · accession 0000899243-18-023729
Seres Therapeutics, Inc. · MCRB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Meryl Zausner
Director
Period of report
Aug 30, 2018
Accepted (ET)
Sep 4, 2018 · 4:49 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001609809
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $8.47 | Aug 30, 2018 | A | 30,000 | A | — | Aug 29, 2028 | Common Stock | 30,000 | 30,000 | D |
Explanation of responses
- F1The option will vest in four equal installments on each anniversary of 08/30/2018 or in full immediately prior to the occurrence of a change in control.